• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾腺癌中肿瘤血管生成因子的检测

Detection of tumor angiogenesis factor in adenocarcinoma of kidney.

作者信息

Bard R H, Mydlo J H, Freed S Z

出版信息

Urology. 1986 May;27(5):447-50. doi: 10.1016/0090-4295(86)90412-7.

DOI:10.1016/0090-4295(86)90412-7
PMID:2422803
Abstract

Implantation of human renal adenocarcinoma in the rabbit cornea has resulted in new vascular growth from the limbus toward the tumor implant. This suggests that renal adenocarcinoma elaborates tumor angiogenesis factor (TAF) which stimulates endothelial cell growth. Such a substance could conceivably be responsible for the luxuriant vascularity of most renal adenocarcinomas. Conversely, absence or diminished secretion of TAF may be responsible for the hypovascular papillary renal adenocarcinomas and their recognized relatively benign clinical behavior.

摘要

将人类肾腺癌植入兔角膜后,已导致从角膜缘向肿瘤植入物方向出现新的血管生长。这表明肾腺癌能产生刺激内皮细胞生长的肿瘤血管生成因子(TAF)。可以想象,这样一种物质可能是大多数肾腺癌丰富血管形成的原因。相反,TAF的缺乏或分泌减少可能是乳头状低血管性肾腺癌及其公认的相对良性临床行为的原因。

相似文献

1
Detection of tumor angiogenesis factor in adenocarcinoma of kidney.肾腺癌中肿瘤血管生成因子的检测
Urology. 1986 May;27(5):447-50. doi: 10.1016/0090-4295(86)90412-7.
2
Initiation of angiogenesis by human follicular fluid.人卵泡液引发血管生成
Science. 1984 Apr 27;224(4647):389-90. doi: 10.1126/science.6200930.
3
Tumour angiogenesis factor (TAF) in human and animal tumours.
Int J Cancer. 1976 May 15;17(5):549-58. doi: 10.1002/ijc.2910170502.
4
Evaluation of tumor angiogenesis factor with the rabbit cornea model.利用兔角膜模型评估肿瘤血管生成因子。
Invest Ophthalmol Vis Sci. 1979 Aug;18(8):831-41.
5
A mathematical model of tumour-induced capillary growth.肿瘤诱导的毛细血管生长的数学模型。
J Theor Biol. 1985 May 7;114(1):53-73. doi: 10.1016/s0022-5193(85)80255-1.
6
Tumor angiogenesis factor (TAF) in cultured cells derived from central nervous system tumors in humans.人中枢神经系统肿瘤来源的培养细胞中的肿瘤血管生成因子(TAF)
Neurol Med Chir (Tokyo). 1981 Jul;21(7):765-73. doi: 10.2176/nmc.21.765.
7
[Tumor-derived growth factors--tumor angiogenic factor].[肿瘤衍生生长因子——肿瘤血管生成因子]
Nihon Rinsho. 1986 Jan;44(1):169-79.
8
Production of a heparin-binding angiogenesis factor by the embryonic kidney.胚胎肾产生一种肝素结合血管生成因子。
J Cell Biol. 1986 Sep;103(3):1101-7. doi: 10.1083/jcb.103.3.1101.
9
Tumour angiogenesis.肿瘤血管生成
J Pathol. 1983 Nov;141(3):385-413. doi: 10.1002/path.1711410315.
10
Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis.与血管生成相关的肾细胞癌中,血管内皮生长因子和胎盘生长因子的信使核糖核酸量显著增加。
Cancer Res. 1994 Aug 1;54(15):4233-7.

引用本文的文献

1
Antitumour and antiangiogenic activities of [Pt(O,O'-acac)(γ-acac)(DMS)] in a xenograft model of human renal cell carcinoma.[Pt(O,O'-乙酰丙酮)(γ-乙酰丙酮)(二甲基亚砜)]在人肾细胞癌异种移植模型中的抗肿瘤和抗血管生成活性
Br J Pharmacol. 2016 Sep;173(17):2633-44. doi: 10.1111/bph.13543. Epub 2016 Jul 22.
2
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma.靶向治疗的基本原理及帕唑帕尼在晚期肾细胞癌中的潜在作用。
Biologics. 2010 Aug 9;4:187-97. doi: 10.2147/btt.s7818.
3
The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy.
VHL在肾透明细胞癌中的作用及其与靶向治疗的关系。
Kidney Int. 2009 Nov;76(9):939-45. doi: 10.1038/ki.2009.296. Epub 2009 Aug 5.
4
The von Hippel-Lindau gene: turning discovery into therapy.冯·希佩尔-林道基因:将发现转化为治疗方法。
Cancer. 2008 Oct 1;113(7 Suppl):1768-78. doi: 10.1002/cncr.23645.
5
The role of angiogenesis in prostate and other urologic cancers: a review.血管生成在前列腺癌及其他泌尿系统癌症中的作用:综述
CMAJ. 2001 Mar 6;164(5):662-70.
6
Growth factors and renal cancer: characterization and therapeutic implications.生长因子与肾癌:特征及治疗意义
World J Urol. 1995;13(6):356-63. doi: 10.1007/BF00191217.
7
Biology of metastasis and its clinical implications: renal-cell cancer.
World J Urol. 1996;14(3):175-81. doi: 10.1007/BF00186897.